Comparability Studies for Later‐Generation Products—Plant‐Made Pharmaceuticals

Abstract

Plant Made Pharmaceuticals (PMPs) use genetically engineered plants to express substances that may be used to treat and cure diseases such as cancer, Alzheimer's disease, diabetes, HIV, heart disease. The boundary technology nature of PMPs places it firmly into limbo in terms of social acceptability and, ultimately, economic viability. This article explores PMPs and their potential with an eye toward public response and policy actions.